[CAS NO. 1228559-81-6] Linaprazanglurate
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [1228559-81-6]
Catalog
AS960258
Brand
Arctom Scientific
CAS
1228559-81-6
DESCRIPTION [1228559-81-6]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 480.56 |
| Molecular Formula | C26H32N4O5 |
| SMILES | O=C(CCCC(OCCNC(C1=CN2C(C)=C(C)N=C2C(NCC3=C(C)C=CC=C3C)=C1)=O)=O)O |
For research use only. We do not sell to patients.
Summary
Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. Linaprazan glurate exhibits several advantageous properties, such as fast onset, high in vivo potency and/or long duration of action. Linaprazan glurate is useful in the research of gastrointestinal inflammatory diseases and peptic ulcer diseases (extracted from patent WO2010063876A1) [1] .
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT05469854 | Cinclus Pharma AG |
Pharmacokinetics|Cardiodynamic ECG|Safety, and Tolerability|GERD
|
July 13, 2022 | Phase 1 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Powered by Arctom Copyright © 2026 Arctom.
All rights reserved.